Valuation: Chrome Holding Co.

Market Cap 96.6M 83.71M 78.37M 71.51M 135M 9.21B 137M 919M 360M 4.61B 363M 355M 15.39B P/E 2024
-0.38x
P/E 2025 -0.07x
Enterprise Value 65.86M 57.08M 53.43M 48.76M 91.75M 6.28B 93.29M 627M 245M 3.14B 247M 242M 10.49B EV / Sales 2024
0.53x
EV / Sales 2025 -0.06x
Free-Float
68.5%
Yield 2024 *
-
Yield 2025 -
1 year 2.41
Extreme 2.41
4.39
3 years 0.47
Extreme 0.4701
29.2
5 years 0.47
Extreme 0.4701
273.6
10 years 0.47
Extreme 0.4701
363.2
Manager TitleAgeSince
Chief Executive Officer 63 2025-03-22
Chief Tech/Sci/R&D Officer - 2024-08-31
Chief Tech/Sci/R&D Officer 48 2006-12-31
Director TitleAgeSince
Chairman 52 2005-12-31
Director/Board Member 57 2024-10-27
Director/Board Member 61 2024-10-27
Date Insider Type Main position Quantity % Market Cap.
8/20/25 Tax

Chief Executive Officer

5,232 0.0206%
6/9/25 Conversion

Founder

4,931,692 25.0063%
5/20/25 Tax

Chief Executive Officer

5,073 0.0257%
Change 5-day change 1-year change 3-year change Capi.($)
-2.78%-.--%-12.50%-88.18% 96.4M
-1.77%+13.64%+99.13%+456.34% 45.08B
+0.35%+3.23%+20.45%+47.90% 26.15B
-1.33%+0.22%-20.30%-34.04% 7.88B
-1.22%+10.29%+23.13%+142.43% 6.01B
+0.52%+3.79%+20.31%+72.86% 3.42B
+4.96%+15.29%-26.05%+1,451.04% 2.44B
-0.60%+1.47%+184.02%+17.57% 2.12B
+1.65%+13.78%+2.48%-50.23% 2.16B
-1.22%+6.29%+30.18%+21.90% 1.96B
Average -0.15%+276.69%+32.08%+203.76% 9.73B
Weighted average by Cap. -0.77%+300.80%+55.93%+268.83%

Financials

2024 2025
Net sales 220M 190M 178M 163M 306M 20.95B 311M 2.09B 819M 10.49B 825M 807M 34.98B 190M 165M 154M 141M 265M 18.11B 269M 1.81B 708M 9.07B 713M 697M 30.24B
Net income -667M -578M -541M -494M -929M -63.59B -944M -6.34B -2.48B -31.83B -2.5B -2.45B -106B -281M -243M -228M -208M -391M -26.79B -398M -2.67B -1.05B -13.41B -1.05B -1.03B -44.74B
Net Debt -140M -121M -114M -104M -195M -13.35B -198M -1.33B -522M -6.68B -526M -514M -22.29B -30.74M -26.63M -24.93M -22.75M -42.81M -2.93B -43.53M -292M -115M -1.47B -115M -113M -4.9B
Logo Chrome Holding Co.
Chrome Holding Co., formerly 23andMe Holding Co., is a genetics-led consumer healthcare company. As a part of TTAM Research Institute (TTAM), the Company operates and provides customers with personalized deoxyribonucleic acid (DNA) testing and research services.
Employees
261
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB